Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Miners Push FTSE 100 Up As Dairy Crest Leads 250

Fri, 22nd Feb 2019 12:29

LONDON (Alliance News) - London share prices were rising at midday, with the mining sector driving the blue-chip index higher, amid investor optimism as a fresh round of US-China trade talks was set to conclude on Friday.The FTSE 100 was 32.51 points higher, or 0.5%, at 7,199.90 on Friday at midday. The mid-cap FTSE 250 was up 69.88 points, or 0.4%, at 19,306.76, while the AIM All-Share index was flat at 908.81.The Cboe UK 100 index was up 0.6% at 12,230.00. The Cboe UK 250 was up 0.5% at 17,210.97. The Cboe UK Small Companies was down 0.2% at 11,162.48.In New York, stocks are pointed to a slightly lower open on Friday with the Dow Jones Industrial Average seen down 0.3%, the S&P 500 called 0.2% lower, and the Nasdaq on course to decline 0.1%.US and Chinese trade negotiators met Thursday at the White House to begin two days of meetings to resolve their trade dispute ahead of a Friday next week deadline.US Trade Representative Robert Lighthizer is leading the US team, while the Chinese side is led by Vice Premier Liu He.The high-level talks come after the latest round of negotiations in Beijing last week ended inconclusively and after a series of meetings between deputies earlier this week in Washington.The White House said Monday the negotiators would discuss "China's pledge to purchase a substantial amount of goods and services from the US"."Markets are showing signs of tentative optimism as Donald Trump lays out plans to meet with Chinese negotiator Liu He. Meanwhile, UK remains well bid as markets expect an extension to the article 50 deadline," said Joshua Mahony, senior market analyst at IG.UK Prime Minister Theresa May has been warned she could face a mass revolt of Conservative members of Parliament if the country appears on course for a no-deal Brexit.The leaders of the 100-strong Brexit Delivery Group of moderate Conservatives wrote to Chief Whip Julian Smith setting out widespread discontent at the prospect of a no-deal departure.Andrew Percy, one of the group's leaders, said dozens of his colleagues would be prepared to vote for measures to delay the March 29 exit date if the "intransigence" of hard-line Brexiteers meant May's deal is again rejected by MPs.Fresh Brexit talks have been scheduled for early next week as May heads towards another Commons showdown on her EU withdrawal stance. It is expected to take place on Wednesday.On the London Stock Exchange, miners were at the top of the FTSE 100 index, with Evraz up 3.1%, Anglo American rising by 2.9%, Glencore up 2.3%, BHP Group up 2.0% and Rio Tinto up 1.5%."It comes as no surprise to see the mining sector drive the FTSE 100 higher, with investors jumping on board amid improving trade sentiment," said Mahony.Barclays was among the worst performers in the blue-chip index, down 1.1%. The bank said Gerry Grimstone, a non-executive director of company and the chair of its retail arm, Barclays Bank, will step down from his role at the end of February. Nigel Higgins, who is joining the lender on Friday next week to be chair-elect of the company, will take over Grimstone's duties.Barclays on Thursday announced a higher dividend and pledged a greater focus on returns to shareholders, after litigation charges pulled down 2018 profit.Pearson was down 1.0% after rising 1.2% in early trade. The publishing company said Friday that pretax profit rose 18% to GBP498 million in 2018 from GBP421 million the year prior, despite revenue falling 8.4% to GBP4.13 billion from GBP4.51 billion.Although reported revenue saw a significant fall in 2018, on an underlying basis it fell a more modest 1%, hurt by Pearson's US Higher Education Courseware and US K12 Courseware businesses, the latter of which has now been sold.Looking ahead, Pearson has reiterated previous guidance for 2019 of adjusted operating profit in the range of GBP590 million to GBP640 million with adjusted earnings per share in the range of 56.5 pence to 62.0p. In 2018, adjusted earnings per share totalled 70.3p.Brokers, meanwhile, expressed mixed views on Pearson's full-year results, with Shore Capital encouraged by the company's financial performance but long-time Pearson sceptic Liberum raising questions on the company's ability to return to growth in 2020.GlaxoSmithKline was down 0.6% after UBS cut the drugmaker to Neutral from Buy.Moving to FTSE 250, Dairy Crest jumped 13% to 625 pence as it agreed a takeover by Canadian dairy firm Saputo.The company, which owns Cathedral City cheddar and Country Life butter, said Saputo will pay 620 pence in cash for each Dairy Crest share. The offer values Dairy Crest at about GBP975 million.The price is a 12% premium to Dairy Crest's closing price of 555p on Thursday, which had gave a market capitalisation of GBP863 million.The purchase will be funded by Saputo from debt, which will be provided under a credit agreement underwritten by the National Bank of Canada and Bank of Montreal. Dairy Crest's existing debt, which stood at GBP265.7 million at the end of March last year, will be refinanced using this credit agreement.Sub-prime lender Non-Standard Finance has made an all-share offer for peer Provident Financial, valuing Provident around GBP1.3 billion.Provident was 7.8% higher on midday, and Non-Standard Finance up 7.3%.The merger will see Non-Standard Finance issue 8.88 of its own shares per Provident share, valuing Provident's shares at around 511 pence each. Provident closed at 511.40p on Thursday, so there is no premium to the takeover proposal.So far, shareholders with over 50% of Provident have indicated they will accept the deal, including Woodford, Invesco, and Marathon.Serco was 5.3% higher, despite CFRA cutting its rating to Hold from Sell. Metro Bank rose 5.0% as it won GBP120 million funding from BCR, which was set up to implement the alternative remedies package agreed between the UK and the European Commission in connection with the taxpayer bailout of Royal Bank of Scotland.By contrast, CYBG was 5.1% lower, after failing to get a grant from the same body.The cash will go towards helping small and medium-sized businesses, Metro Bank said.Elsewhere, Flybe slumped 22%. It has completed the sale of operating subsidiaries Flybe Ltd and Flybe.com to Connect Airways, a consortium including Stobart Group.Flybe Group, now a non-trading entity, itself still needs shareholder approval to be sold, and the board has warned without a sale it will be wound up.Stobart Group, as part of the deal, has sold its Stobart Air and Propius businesses to Connect Airways, and this now also has completed. Stobart was up 4.7%.In mainland Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were up 0.3% and 0.5% higher, respectively at midday. Euro area annual inflation rate was 1.4% in January 2019, slowing from 1.5% in December, according to figures published on Friday by Eurostat. Annual inflation in the entire 28-nation European Union was 1.5% in January 2019, slowing from 1.6% in December. Still to come in the economic calendar on Friday is a speech by European Central Bank President Mario Draghi speech at 1530 GMT.

More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.